SARAH BAKER: Open Payments
NPI 1710375191 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 33 payments from 10 companies in 2025. Trend: 2023 $776 · 2024 $781 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $254 |
| Otsuka America Pharmaceutical, Inc. | 7 | $146 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Amgen Inc. | 3 | $54 |
| Exact Sciences Corporation | 2 | $28 |
| Philips North America LLC | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
Products named: REXULTI, AIRSUPRA, FARXIGA, Auvelity, CAPLYTA, OTEZLA, Cologuard Collection Kit, Vest Therapy Und.
Industry payments across MO — which companies pay providers there.
